Skip to main content

Survey of 300 Rheums, GI, Derms - concerns w/ new biosimilars - majority say economics arent favorable to switch to bios

Feb 26, 2023 10:00 am
Social Author Name
Dr. John Cush
Tweet Content
Survey of 300 Rheums, GI, Derms - concerns w/ new biosimilars - majority say economics arent favorable to switch to biosimilar - Yet majority "very to somewhat” comfortable w/ biosimilars - US: Slow biosimilar uptake due to disappointing costs https://t.co/DOhrfELssY https://t.co/f2iy9igq5d
Show on Archive Page
On
Display in Search Results
On
PDQ
Off